Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

COVID-19 vaccine developer cautious on 2020 roll-out

COVID-19 vaccine developer cautious on 2020 roll-out

ALISTAIR SMOUT  THE University of Oxford's possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine has announced. The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of 2020. "The end of the year target for getting vaccine roll-out, it's a possibility but there's absolutely no certainty about that because we need three things to happen," Sarah Gilbert told BBC Radio. She said it…
Read More
Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September – researcher

Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September – researcher

EARLY estimates of the production of a million doses of the University of Oxford's experimental COVID-19 vaccine by September could be an underestimate depending on how quickly late-stage trials can be completed, a researcher has said. "There might be a million doses manufactured by September: that now seems like a remarkable underestimate, given the scale of what's going on," Adrian Hill of the University of Oxford said, referring to the manufacturing capability of partner AstraZeneca. "Certainly there'll be a million doses around in September. What's less predictable than the manufacturing scale-up is the incidence of disease, so when there'll be…
Read More